Eugene Shkolyar, MD - Stanford Cancer Center Urologic Cancer Program in Palo Alto

Located in the vibrant city of Palo Alto CA you'll find Dr. Jennifer C Kao a dedicated provider at Stanford Health Breast Imaging Service. With a background in allopathic medicine Dr. Kao holds the prestigious title of M.D. signifying her expertise as a medical doctor in general practice. Specializing in breast imaging Dr. Kao brings a wealth of knowledge and experience to her patients. By combining her medical skills with a compassionate approach she strives to provide top-notch care to those seeking diagnostic and screening services in the Palo Alto area. Generated from this place's public information

Sandhya Srinivas, MD, part of the Stanford University Oncology Department in Palo Alto, CA, stands as a beacon of excellence in cancer care. Aligned with Stanford Health Care, this facility boasts cutting-edge treatments and research in oncology, providing a nurturing environment for patients seeking specialized cancer therapies. With a focus on delivering personalized care and leveraging the latest advancements in cancer treatment, Sandhya Srinivas, MD, and their team strive to enhance patient outcomes and quality of life. Located within the renowned Stanford Health Care network, this facility integrates seamlessly with academic excellence and a multidisciplinary approach to cancer care. Patients can expect top-tier medical expertise in a supportive and innovative setting that prioritizes holistic well-being. From diagnosis to survivorship, Sandhya Srinivas, MD, at Stanford University Oncology Department is dedicated to offering compassionate care and pioneering solutions that redefine the landscape of cancer treatment. Generated using this brand's available information

Youn H. Kim, M.D., is a Professor of Dermatology and member of the Stanford Cancer Institute. She is the Director of Stanford's Multidisciplinary Cutaneous Lymphoma Clinic/Program (MCLP). Her current research is dedicated towards strengthening the collaborative interface for novel discoveries and exploring new and improved therapies with tumor-specific targets and enhanced synergy and/or potency. She and her multidisciplinary colleagues are exploring novel immune/cell therapy modalities including in situ vaccination, immune checkpoint blockades, and unique allogeneic HSCT strategies.